<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Germline mutation of NF2 gene is a feature of <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> type 2 familial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>Also, somatic point mutations of NF2 mutation have been reported in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> originated from nerve structures </plain></SENT>
<SENT sid="2" pm="."><plain>A recent study revealed that NF2 gene was mutated in <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo> (<z:chebi fb="60" ids="47899">RCC</z:chebi>) as well, suggesting a possibility that NF2 gene might be somatically mutated in other human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to explore whether NF2 genes are somatically mutated, and contribute to <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in common human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: For this, we analysed the entire coding region of NF2 gene in 45 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, 45 gastric, 45 breast, 45 lung, 45 hepatocellular (<z:mp ids='MP_0003331'>HCC</z:mp>), 45 prostate <z:mp ids='MP_0002038'>carcinomas</z:mp>, and 45 <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> by a single-strand conformation polymorphism assay </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Overall, we found NF2 mutations in one <z:mp ids='MP_0003331'>HCC</z:mp> (1/45; 2.2%) (<z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus-related <z:mp ids='MP_0003331'>HCC</z:mp>), one <z:mp ids='MP_0008714'>lung carcinoma</z:mp> (1/45; 2.2%) (<z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo>), and one <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (1/45; 2.2%) (<z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> minimally differentiated) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the mutations were missense mutations that would substitute amino acids in the NF2 protein (p.A238â€ŠV, p.A451T and p.R467K) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our data indicate that <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> of NF2 gene is not prevalent in common human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, and its mutation somatically occurs in a minor fraction of <z:mp ids='MP_0003331'>HCC</z:mp>, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>These data suggest that <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> of NF2 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene may not play a central role in development of common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>